These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 861451)

  • 21. [Effect of hypoxic cell sensitizer metronidazole on the radiation reaction of clonogenic cells from solid tumors].
    Gulverdashvili NA; Afanas'ev GG; Pelevina II
    Radiobiologiia; 1987; 27(5):636-40. PubMed ID: 3671679
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Repair of potentially lethal damage following irradiation with X rays or cyclotron neutrons: response of the EMT-6/uw tumor system treated under various growth conditions in vitro and in vivo.
    Rasey JS; Nelson NJ
    Radiat Res; 1981 Jan; 85(1):69-84. PubMed ID: 7465780
    [No Abstract]   [Full Text] [Related]  

  • 23. The potentiation of radiation damage by nicotinamide in the SCCVII tumour in vivo.
    Horsman MR; Wood PJ; Chaplin DJ; Brown JM; Overgaard J
    Radiother Oncol; 1990 May; 18(1):49-57. PubMed ID: 2141694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recovery from potentially lethal damage after X-irradiation in three experimental tumors in mice.
    Shibamoto Y; Takahashi M; Ono K; Komuro C; Abe M
    Jpn J Cancer Res; 1985 Apr; 76(4):278-83. PubMed ID: 3924702
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cure, regression and cell survival: a comparison of common radiobiological endpoints using an in vitro tumour model.
    Durand RE
    Br J Radiol; 1975 Jul; 48(571):556-71. PubMed ID: 1148588
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of manganese superoxide dismutase reduces tumor control radiation dose: gene-radiotherapy.
    Urano M; Kuroda M; Reynolds R; Oberley TD; St Clair DK
    Cancer Res; 1995 Jun; 55(12):2490-3. PubMed ID: 7780953
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Repair of radiation damage in Lewis lung carcinoma cells following in situ treatment with fast neutrons and gamma-rays.
    Shipley WU; Stanley JA; Courtenay VD; Field SB
    Cancer Res; 1975 Apr; 35(4):932-8. PubMed ID: 1120301
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparison of the effects of radiation on tumour growth delay and cell survival. The effect of radiation quality.
    McNally NJ
    Br J Radiol; 1975 Feb; 48(566):141-5. PubMed ID: 1125537
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recovery from potentially lethal damage following irradiation with X-rays or cyclotron neutrons--I. Response of EMT-6 cells in vitro.
    Rasey JS; Nelson NJ; Carpenter RE
    Int J Radiat Oncol Biol Phys; 1978; 4(11-12):1023-7. PubMed ID: 721646
    [No Abstract]   [Full Text] [Related]  

  • 30. Importance of repair of potentially lethal damage in assays of cytotoxic agents.
    Richie JP; Weichselbaum RR; Little JB
    Surgery; 1982 Aug; 92(2):380-4. PubMed ID: 7101131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Compatibility of the linear-quadratic formalism and biologically effective dose concept to high-dose-per-fraction irradiation in a murine tumor.
    Otsuka S; Shibamoto Y; Iwata H; Murata R; Sugie C; Ito M; Ogino H
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1538-43. PubMed ID: 22115556
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of tumour response in a rat rhabdomyosarcoma.
    Curtis SB; Tenforde TS
    Br J Cancer Suppl; 1980 Apr; 4():266-70. PubMed ID: 6932935
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dose-response curve and split-dose recovery in human skin cancer.
    Trott KR; Maciejewski B; Preuss-Bayer G; Skolyszewski J
    Radiother Oncol; 1984 Aug; 2(2):123-9. PubMed ID: 6505282
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Variation in the hypoxic fraction among mouse tumors of different types, sizes, and sites.
    Shibamoto Y; Yukawa Y; Tsutsui K; Takahashi M; Abe M
    Jpn J Cancer Res; 1986 Sep; 77(9):908-15. PubMed ID: 3095287
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metronidazole (Flagyl): characterization as a cytotoxic drug specific for hypoxic tumour cells.
    Foster JL; Conroy PJ; Searle AJ; Willson RL
    Br J Cancer; 1976 May; 33(5):485-90. PubMed ID: 1276030
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lack of differential radiosensitization of hypoxic cells in a mouse tumor at low radiation doses per fraction by cisplatin.
    Sun JR; Brown JM
    Radiat Res; 1993 Feb; 133(2):252-6. PubMed ID: 8438067
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypoxic fraction determinations with the BA1112 rat sarcoma: variation within and among assay techniques.
    Moulder JE; Martin DF
    Radiat Res; 1984 Jun; 98(3):536-48. PubMed ID: 6729051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of tumour size on radiosensitization by misonidazole.
    Stanley JA; Peckham MJ; Steel GG
    Br J Cancer Suppl; 1978 Jun; 3():220-4. PubMed ID: 277232
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumour bed effect: hypoxic fraction of tumours growing in preirradiated beds.
    Penhaligon M; Courtenay VD; Camplejohn RS
    Int J Radiat Biol Relat Stud Phys Chem Med; 1987 Oct; 52(4):635-41. PubMed ID: 2444545
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiosensitizing and cytocidal effects on hypoxic cells of RO-07-0582, and repair of x-ray injury, in an experimental mouse tumour.
    Hill SA; Fowler JF
    Br J Cancer; 1977 Apr; 35(4):461-9. PubMed ID: 869984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.